Thrombocytopenia Management Market - Global Outlook and Forecast 2022-2028

January 2022 | 68 pages | ID: TF180B4C4220EN
Market Monitor Global

Abstracts

Thrombocytopenia is deficiency of platelets in the blood vessels, an auto immune hematological bleeding disorder.

This report contains market size and forecasts of Thrombocytopenia Management in Global, including the following market information:

Global Thrombocytopenia Management Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Thrombocytopenia Management market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Idiopathic Thrombocytopenic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Thrombocytopenia Management include Amarillo Biosciences, Amgen, Baxalta, Bayer, BioLineRx, Boehringer Ingelheim, Bolder Biotechnology, Bristol-Myers Squibb and Cellerant Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thrombocytopenia Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Thrombocytopenia Management Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Thrombocytopenia Management Market Segment Percentages, by Type, 2021 (%)

• Idiopathic Thrombocytopenic
• Thrombotic Thrombocytopenic
• Drug-induced Thrombocytopenia

Global Thrombocytopenia Management Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Thrombocytopenia Management Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Speciality Clinics
• Ambulatory Surgical Centres

Global Thrombocytopenia Management Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Thrombocytopenia Management Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Thrombocytopenia Management revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Thrombocytopenia Management revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amarillo Biosciences
• Amgen
• Baxalta
• Bayer
• BioLineRx
• Boehringer Ingelheim
• Bolder Biotechnology
• Bristol-Myers Squibb
• Cellerant Therapeutics
• Eisai
• Genosco
• Hansa Medical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Thrombocytopenia Management Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Thrombocytopenia Management Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL THROMBOCYTOPENIA MANAGEMENT OVERALL MARKET SIZE

2.1 Global Thrombocytopenia Management Market Size: 2021 VS 2028
2.2 Global Thrombocytopenia Management Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Thrombocytopenia Management Players in Global Market
3.2 Top Global Thrombocytopenia Management Companies Ranked by Revenue
3.3 Global Thrombocytopenia Management Revenue by Companies
3.4 Top 3 and Top 5 Thrombocytopenia Management Companies in Global Market, by Revenue in 2021
3.5 Global Companies Thrombocytopenia Management Product Type
3.6 Tier 1, Tier 2 and Tier 3 Thrombocytopenia Management Players in Global Market
  3.6.1 List of Global Tier 1 Thrombocytopenia Management Companies
  3.6.2 List of Global Tier 2 and Tier 3 Thrombocytopenia Management Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Thrombocytopenia Management Market Size Markets, 2021 & 2028
  4.1.2 Idiopathic Thrombocytopenic
  4.1.3 Thrombotic Thrombocytopenic
  4.1.4 Drug-induced Thrombocytopenia
4.2 By Type - Global Thrombocytopenia Management Revenue & Forecasts
  4.2.1 By Type - Global Thrombocytopenia Management Revenue, 2017-2022
  4.2.2 By Type - Global Thrombocytopenia Management Revenue, 2023-2028
  4.2.3 By Type - Global Thrombocytopenia Management Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Thrombocytopenia Management Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Speciality Clinics
  5.1.4 Ambulatory Surgical Centres
5.2 By Application - Global Thrombocytopenia Management Revenue & Forecasts
  5.2.1 By Application - Global Thrombocytopenia Management Revenue, 2017-2022
  5.2.2 By Application - Global Thrombocytopenia Management Revenue, 2023-2028
  5.2.3 By Application - Global Thrombocytopenia Management Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Thrombocytopenia Management Market Size, 2021 & 2028
6.2 By Region - Global Thrombocytopenia Management Revenue & Forecasts
  6.2.1 By Region - Global Thrombocytopenia Management Revenue, 2017-2022
  6.2.2 By Region - Global Thrombocytopenia Management Revenue, 2023-2028
  6.2.3 By Region - Global Thrombocytopenia Management Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Thrombocytopenia Management Revenue, 2017-2028
  6.3.2 US Thrombocytopenia Management Market Size, 2017-2028
  6.3.3 Canada Thrombocytopenia Management Market Size, 2017-2028
  6.3.4 Mexico Thrombocytopenia Management Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Thrombocytopenia Management Revenue, 2017-2028
  6.4.2 Germany Thrombocytopenia Management Market Size, 2017-2028
  6.4.3 France Thrombocytopenia Management Market Size, 2017-2028
  6.4.4 U.K. Thrombocytopenia Management Market Size, 2017-2028
  6.4.5 Italy Thrombocytopenia Management Market Size, 2017-2028
  6.4.6 Russia Thrombocytopenia Management Market Size, 2017-2028
  6.4.7 Nordic Countries Thrombocytopenia Management Market Size, 2017-2028
  6.4.8 Benelux Thrombocytopenia Management Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Thrombocytopenia Management Revenue, 2017-2028
  6.5.2 China Thrombocytopenia Management Market Size, 2017-2028
  6.5.3 Japan Thrombocytopenia Management Market Size, 2017-2028
  6.5.4 South Korea Thrombocytopenia Management Market Size, 2017-2028
  6.5.5 Southeast Asia Thrombocytopenia Management Market Size, 2017-2028
  6.5.6 India Thrombocytopenia Management Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Thrombocytopenia Management Revenue, 2017-2028
  6.6.2 Brazil Thrombocytopenia Management Market Size, 2017-2028
  6.6.3 Argentina Thrombocytopenia Management Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Thrombocytopenia Management Revenue, 2017-2028
  6.7.2 Turkey Thrombocytopenia Management Market Size, 2017-2028
  6.7.3 Israel Thrombocytopenia Management Market Size, 2017-2028
  6.7.4 Saudi Arabia Thrombocytopenia Management Market Size, 2017-2028
  6.7.5 UAE Thrombocytopenia Management Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amarillo Biosciences
  7.1.1 Amarillo Biosciences Corporate Summary
  7.1.2 Amarillo Biosciences Business Overview
  7.1.3 Amarillo Biosciences Thrombocytopenia Management Major Product Offerings
  7.1.4 Amarillo Biosciences Thrombocytopenia Management Revenue in Global Market (2017-2022)
  7.1.5 Amarillo Biosciences Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Thrombocytopenia Management Major Product Offerings
  7.2.4 Amgen Thrombocytopenia Management Revenue in Global Market (2017-2022)
  7.2.5 Amgen Key News
7.3 Baxalta
  7.3.1 Baxalta Corporate Summary
  7.3.2 Baxalta Business Overview
  7.3.3 Baxalta Thrombocytopenia Management Major Product Offerings
  7.3.4 Baxalta Thrombocytopenia Management Revenue in Global Market (2017-2022)
  7.3.5 Baxalta Key News
7.4 Bayer
  7.4.1 Bayer Corporate Summary
  7.4.2 Bayer Business Overview
  7.4.3 Bayer Thrombocytopenia Management Major Product Offerings
  7.4.4 Bayer Thrombocytopenia Management Revenue in Global Market (2017-2022)
  7.4.5 Bayer Key News
7.5 BioLineRx
  7.5.1 BioLineRx Corporate Summary
  7.5.2 BioLineRx Business Overview
  7.5.3 BioLineRx Thrombocytopenia Management Major Product Offerings
  7.5.4 BioLineRx Thrombocytopenia Management Revenue in Global Market (2017-2022)
  7.5.5 BioLineRx Key News
7.6 Boehringer Ingelheim
  7.6.1 Boehringer Ingelheim Corporate Summary
  7.6.2 Boehringer Ingelheim Business Overview
  7.6.3 Boehringer Ingelheim Thrombocytopenia Management Major Product Offerings
  7.6.4 Boehringer Ingelheim Thrombocytopenia Management Revenue in Global Market (2017-2022)
  7.6.5 Boehringer Ingelheim Key News
7.7 Bolder Biotechnology
  7.7.1 Bolder Biotechnology Corporate Summary
  7.7.2 Bolder Biotechnology Business Overview
  7.7.3 Bolder Biotechnology Thrombocytopenia Management Major Product Offerings
  7.7.4 Bolder Biotechnology Thrombocytopenia Management Revenue in Global Market (2017-2022)
  7.7.5 Bolder Biotechnology Key News
7.8 Bristol-Myers Squibb
  7.8.1 Bristol-Myers Squibb Corporate Summary
  7.8.2 Bristol-Myers Squibb Business Overview
  7.8.3 Bristol-Myers Squibb Thrombocytopenia Management Major Product Offerings
  7.8.4 Bristol-Myers Squibb Thrombocytopenia Management Revenue in Global Market (2017-2022)
  7.8.5 Bristol-Myers Squibb Key News
7.9 Cellerant Therapeutics
  7.9.1 Cellerant Therapeutics Corporate Summary
  7.9.2 Cellerant Therapeutics Business Overview
  7.9.3 Cellerant Therapeutics Thrombocytopenia Management Major Product Offerings
  7.9.4 Cellerant Therapeutics Thrombocytopenia Management Revenue in Global Market (2017-2022)
  7.9.5 Cellerant Therapeutics Key News
7.10 Eisai
  7.10.1 Eisai Corporate Summary
  7.10.2 Eisai Business Overview
  7.10.3 Eisai Thrombocytopenia Management Major Product Offerings
  7.10.4 Eisai Thrombocytopenia Management Revenue in Global Market (2017-2022)
  7.10.5 Eisai Key News
7.11 Genosco
  7.11.1 Genosco Corporate Summary
  7.11.2 Genosco Business Overview
  7.11.3 Genosco Thrombocytopenia Management Major Product Offerings
  7.11.4 Genosco Thrombocytopenia Management Revenue in Global Market (2017-2022)
  7.11.5 Genosco Key News
7.12 Hansa Medical
  7.12.1 Hansa Medical Corporate Summary
  7.12.2 Hansa Medical Business Overview
  7.12.3 Hansa Medical Thrombocytopenia Management Major Product Offerings
  7.12.4 Hansa Medical Thrombocytopenia Management Revenue in Global Market (2017-2022)
  7.12.5 Hansa Medical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Thrombocytopenia Management Market Opportunities & Trends in Global Market
Table 2. Thrombocytopenia Management Market Drivers in Global Market
Table 3. Thrombocytopenia Management Market Restraints in Global Market
Table 4. Key Players of Thrombocytopenia Management in Global Market
Table 5. Top Thrombocytopenia Management Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Thrombocytopenia Management Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Thrombocytopenia Management Revenue Share by Companies, 2017-2022
Table 8. Global Companies Thrombocytopenia Management Product Type
Table 9. List of Global Tier 1 Thrombocytopenia Management Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Thrombocytopenia Management Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Thrombocytopenia Management Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Thrombocytopenia Management Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Thrombocytopenia Management Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Thrombocytopenia Management Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Thrombocytopenia Management Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Thrombocytopenia Management Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Thrombocytopenia Management Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Thrombocytopenia Management Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Thrombocytopenia Management Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Thrombocytopenia Management Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Thrombocytopenia Management Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Thrombocytopenia Management Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Thrombocytopenia Management Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Thrombocytopenia Management Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Thrombocytopenia Management Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Thrombocytopenia Management Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Thrombocytopenia Management Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Thrombocytopenia Management Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Thrombocytopenia Management Revenue, (US$, Mn), 2023-2028
Table 30. Amarillo Biosciences Corporate Summary
Table 31. Amarillo Biosciences Thrombocytopenia Management Product Offerings
Table 32. Amarillo Biosciences Thrombocytopenia Management Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Thrombocytopenia Management Product Offerings
Table 35. Amgen Thrombocytopenia Management Revenue (US$, Mn), (2017-2022)
Table 36. Baxalta Corporate Summary
Table 37. Baxalta Thrombocytopenia Management Product Offerings
Table 38. Baxalta Thrombocytopenia Management Revenue (US$, Mn), (2017-2022)
Table 39. Bayer Corporate Summary
Table 40. Bayer Thrombocytopenia Management Product Offerings
Table 41. Bayer Thrombocytopenia Management Revenue (US$, Mn), (2017-2022)
Table 42. BioLineRx Corporate Summary
Table 43. BioLineRx Thrombocytopenia Management Product Offerings
Table 44. BioLineRx Thrombocytopenia Management Revenue (US$, Mn), (2017-2022)
Table 45. Boehringer Ingelheim Corporate Summary
Table 46. Boehringer Ingelheim Thrombocytopenia Management Product Offerings
Table 47. Boehringer Ingelheim Thrombocytopenia Management Revenue (US$, Mn), (2017-2022)
Table 48. Bolder Biotechnology Corporate Summary
Table 49. Bolder Biotechnology Thrombocytopenia Management Product Offerings
Table 50. Bolder Biotechnology Thrombocytopenia Management Revenue (US$, Mn), (2017-2022)
Table 51. Bristol-Myers Squibb Corporate Summary
Table 52. Bristol-Myers Squibb Thrombocytopenia Management Product Offerings
Table 53. Bristol-Myers Squibb Thrombocytopenia Management Revenue (US$, Mn), (2017-2022)
Table 54. Cellerant Therapeutics Corporate Summary
Table 55. Cellerant Therapeutics Thrombocytopenia Management Product Offerings
Table 56. Cellerant Therapeutics Thrombocytopenia Management Revenue (US$, Mn), (2017-2022)
Table 57. Eisai Corporate Summary
Table 58. Eisai Thrombocytopenia Management Product Offerings
Table 59. Eisai Thrombocytopenia Management Revenue (US$, Mn), (2017-2022)
Table 60. Genosco Corporate Summary
Table 61. Genosco Thrombocytopenia Management Product Offerings
Table 62. Genosco Thrombocytopenia Management Revenue (US$, Mn), (2017-2022)
Table 63. Hansa Medical Corporate Summary
Table 64. Hansa Medical Thrombocytopenia Management Product Offerings
Table 65. Hansa Medical Thrombocytopenia Management Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Thrombocytopenia Management Segment by Type in 2021
Figure 2. Thrombocytopenia Management Segment by Application in 2021
Figure 3. Global Thrombocytopenia Management Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Thrombocytopenia Management Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Thrombocytopenia Management Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Thrombocytopenia Management Revenue in 2021
Figure 8. By Type - Global Thrombocytopenia Management Revenue Market Share, 2017-2028
Figure 9. By Application - Global Thrombocytopenia Management Revenue Market Share, 2017-2028
Figure 10. By Region - Global Thrombocytopenia Management Revenue Market Share, 2017-2028
Figure 11. By Country - North America Thrombocytopenia Management Revenue Market Share, 2017-2028
Figure 12. US Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Thrombocytopenia Management Revenue Market Share, 2017-2028
Figure 16. Germany Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 17. France Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Thrombocytopenia Management Revenue Market Share, 2017-2028
Figure 24. China Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 28. India Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Thrombocytopenia Management Revenue Market Share, 2017-2028
Figure 30. Brazil Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Thrombocytopenia Management Revenue Market Share, 2017-2028
Figure 33. Turkey Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Thrombocytopenia Management Revenue, (US$, Mn), 2017-2028
Figure 37. Amarillo Biosciences Thrombocytopenia Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Thrombocytopenia Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Baxalta Thrombocytopenia Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bayer Thrombocytopenia Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BioLineRx Thrombocytopenia Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boehringer Ingelheim Thrombocytopenia Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bolder Biotechnology Thrombocytopenia Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bristol-Myers Squibb Thrombocytopenia Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cellerant Therapeutics Thrombocytopenia Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eisai Thrombocytopenia Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Genosco Thrombocytopenia Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Hansa Medical Thrombocytopenia Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)